(Q53412730)

English

Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15).

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

phase III clinical trial

0 references

0 references

author name string

Andrea Bezjak

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Peter Dixon

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Michael Brundage

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Dong Tu

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Michael J Palmer

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Paul Blood

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Clive Grafton

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Catherine Lochrin

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Carson Leong

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Liam Mulroy

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Colum Smith

11

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

James Wright

12

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Joseph L Pater

13

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Clinical Trials Group of the National Cancer Institute of Canada

14

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

54

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

719-728

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Wor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative radiation for stage 3 non-small cell lung cancer--a prospective study of two moderately high dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative radiotherapy for lung cancer: two versus five fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

[Radiotherapy for stage III, inoperable, asymptomatic small cell lung cancer. Final results of a prospective randomized study (240 patients)]

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902989-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(02)02989-9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/12377323

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53412730&oldid=2099739486"